Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System SelectionBusiness Wire • Tuesday
Stevanato Group to Report Third Quarter 2026 Financial Results on November 3, 2026Business Wire • 10/20/26
Stevanato Group S.p.A. (STVN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/15/26
Is Stevanato (STVN) a Solid Growth Stock? 3 Reasons to Think "Yes"Zacks Investment Research • 08/05/26
Stevanato Group Delivers 8% Revenue Growth for the Second Quarter of Fiscal 2026Business Wire • 08/04/26
Liraglutide Combination Products Incorporating Stevanato Group's Alina® Pen Injector Received Marketing Authorizations in Multiple European CountriesBusiness Wire • 07/30/26
Stevanato Group to Report Second Quarter 2026 Financial Results on August 4, 2026Business Wire • 07/21/26
Stevanato: HVS Momentum Overshadows Engineering Weakness, Offering Compelling UpsideSeeking Alpha • 06/11/26
Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight ManagementBusiness Wire • 06/08/26
Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders' MeetingBusiness Wire • 06/03/26
Stevanato Group S.p.A. (STVN) Presents at Bank of America Global Healthcare Conference 2026 TranscriptSeeking Alpha • 05/12/26
Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026Business Wire • 05/07/26